Digital Health Impact 2020

September 30, 2020 9:30 AM - 2:00 PM

Online Conference, Link will be sent in advance of the event.

Add to Calendar 9/30/2020 9:30:00 AM 9/30/2020 2:00:00 PM Digital Health Impact 2020

The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, supplementing clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

Join MassBio for our annual Digital Health Impact 2020 event as we examine the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities for collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for therapeutics and digital health innovators to converge and ultimately deliver better outcomes for patients.

Please contact Laura Rudberg for sponsorship opportunities.

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

Online Conference, Link will be sent in advance of the event.

The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, supplementing clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

Join MassBio for our annual Digital Health Impact 2020 event as we examine the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities for collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for therapeutics and digital health innovators to converge and ultimately deliver better outcomes for patients.

Please contact Laura Rudberg for sponsorship opportunities.

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

Director of Innovation, Digital Medicine Society
Rachel Chasse is the Director of Innovation for the Digital Medicine Society (DiMe), the professional society for the field of digital medicine. At DiMe, she curates educational programming, leads diversity efforts, and manages patient engagement initiatives, among others. Prior, she worked at Pfizer in Cambridge, MA in the Digital Medicine and Clinical Sciences groups, operationalizing digital inclusions such as mobile apps and wearable technology into the company’s clinical trials. She received her Master’s of Science in Clinical Research Management from Washington University in St. Louis where her career began in Alzheimer’s disease and dementia research. She lives in Chicago.

Brought to you by